Login to Your Account



CellTherapy Firm Healthpoint Nabbed in $782M Acquisition

By Catherine Shaffer
Staff Writer

Thursday, November 29, 2012

Medical technology firm Smith & Nephew plc, of London, picked up Fort Worth, Texas-based cell therapy company Healthpoint Biotherapeutics for $782 million in cash. Healthpoint markets Collagenase Santyl ointment, and has a cell therapy product, HP802-247, in Phase III testing for wound healing.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription